Prediction to patient

The drug discovery journey

We believe that effective treatments for rare diseases cannot be discovered without the help of patients, their carers, or representatives from patient groups.

Here we’ll look at how essential they are throughout our entire drug development process. Look out for the rare disease   symbol along the way which highlights key information for patients, showing how they impact each stage of drug development.

   
A basic HTML table
Company Contact Country
Alfreds Futterkiste Maria Anders Germany
Centro comercial Moctezuma Francisco Chang Mexico
To understand the example better, we have added borders to the table.  
   
A basic HTML table
Company Contact Country
Alfreds Futterkiste Maria Anders Germany
Centro comercial Moctezuma Francisco Chang Mexico
To understand the example better, we have added borders to the table.  
   
A basic HTML table
Company Contact Country
Alfreds Futterkiste Maria Anders Germany
Centro comercial Moctezuma Francisco Chang Mexico
To understand the example better, we have added borders to the table.  
   
A basic HTML table
Company Contact Country
Alfreds Futterkiste Maria Anders Germany
Centro comercial Moctezuma Francisco Chang Mexico
To understand the example better, we have added borders to the table.  
   
A basic HTML table
Company Contact Country
Alfreds Futterkiste Maria Anders Germany
Centro comercial Moctezuma Francisco Chang Mexico
To understand the example better, we have added borders to the table.  

References

www.healx.ai
www.statista.com/statistics/732997/number-of-registered-clinical-studies-worldwide/
www.fda.gov/patients/drug-development-process/step-3-clinical-research
www.translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0838-4
www.pubmed.ncbi.nlm.nih.gov/29255791/
www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development